Direct 99mTc Labeling of Pegylated Liposomal Doxorubicin (Doxil) for Pharmacokinetic and Non-Invasive Imaging Studies

Journal of Pharmacology and Experimental Therapeutics

Volumn 308, Issue 2, 2004, Pages 419-425

  Bao, Ande ^a   Goins, Beth ^a   Klipper, Robert ^a   Negrete, George ^b   Phillips, William T ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; BOVINE SERUM ALBUMIN; DOXORUBICIN; ETHYLENEDIAMINE DERIVATIVE; N,N BIS(2 MERCAPTOETHYL) N',N' DIETHYLETHYLENEDIAMINE; RHENIUM 186; RHENIUM 188; TECHNETIUM 99M; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MONITORING; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SCINTIGRAPHY; ANIMAL; BLOOD; CHEMISTRY; MALE; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; MALE; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 1542349909     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.059535     Document Type: Article

References (39)

1. Aboagye EO, Price PM, and Jones T (2001) In vivo pharmacokinetics and pharmocodynamics in drug development using positron-emission tomography. Drug Discov Today 6:293-302.
2. Allen TM and Hansen C (1991) Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta 1068:133-141.
3. Androulakis N, Kouroussis C, Mavroudis D, Kakolyris S, Souglakos J, Agelaki S, Kalbakis K, Malas K, Pallis A, Samonis G, et al. (2002) Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours. Eur J Cancer 38:1992-1997.
4. 99mTc-" SNS/S" complexes: in vitro and in vivo evaluation. J Pharm Sci 92:1893-1904.
5. 186Re-"SNS/S" complexes for radionuclide therapy. J Nucl Med 44:306P.
6. Chonn A, Semple SC, and Cullis PR (1991) Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo. Biochim Biophys Acta 1070:215-222.
7. Contag PR (2002) Whole-animal cellular and molecular imaging to accelerate drug development. Drug Discov Today 7:555-562.
8. 2+ core. Inorg Chim Acta 90:41-51.
9. Daemen T, Hofstede G, Ten Kate MT, Bakker-Woundenberg IA, and Scherphof GL (1995) Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages. Int J Cancer 61:716-721.
10. 3+-bound inulin. Biochim Biophys Acta 944:329-336.
11. Frank DW (1976) Physiological data of laboratory animals, in Handbook of Laboratory Animal Science (Melby EC Jr and Altman NH eds) vol 3, pp 23-64, CRC Press, Boca Raton, FL.
12. Gabizon AA (1992) Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52:891-896.
13. Gabizon A, Shmeeda H, and Barenholz Y (2003) Pharmacokinetics of pegylated liposomal doxorubicin. Review of animal and human studies. Clin Pharmacokinet 42:419-436.
14. 188Re incorporated in liposomes suitable for radiotherapy. Nucl Med Biol 18:449-454.
15. Haran G, Cohen R, Bar LK, and Barenholz Y (1993) Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of the amphipathic week bases. Biochim Biophys Acta 1151:201-215.
16. Harashima H, Ishida T, Kamiya H, and Kiwada H (2002) Pharmacokinetics of targeting with liposomes. Crit Rev Ther Drug Carrier Syst 19:235-275.
17. Harrington KJ, Lewanski CR, and Stewart JS (2000a) Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development. Clin Oncol (R Coll Radiol) 12:2-15.
18. Harrington KJ, Lewanski CR, and Stewart JS (2000b) Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical development. Clin Oncol (R Coll Radiol) 12:16-24.
19. Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, Simon J, and Stewart W (2001) Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled liposomes. Clin Cancer Res 7:243-254.
20. Harrington KJ, Rowlinson-Busza G, Syrigos KN, Uster PS, Vile RG, and Stewart JSW (2000c) Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery. Clin Cancer Res 6:2528-2537.
21. Iden DL and Allen TM (2001) In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim Biophys Acta 1513:207-216.
22. 111In-tagged liposomes. Nucl Med Biol 14:33-35.
23. Koukourakis MI, Koukouraki S, Giatromanolaki A, Kakolyris S, Georgoulias V, Velidaki A, Archimandritis S, and Karkavitsas NN (2000) High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas-rationale for combination with radiotherapy. Acta Oncol 39:207-211.
24. 99mTc-labelled stealth liposomal doxorubicin (Caelyx) in glioblastomas and metastatic brain tumours. Br J Cancer 86:659-660.
25. Laverman P, Carstens MG, Boerman OC, Dams ETM, Oyen WJG, Pooijen NV, Corstens FHM, and Storm G (2001) Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther 298:607-612.
26. 99mTc by the hydrazino nicotinyl derivative. J Nucl Med 40:192-197.
27. Matteucci ML, Anyaramdhatla G, Rosner G, Azuma C, Fisher PE, Dewhirst MW, Needham D, and Thrall DE (2000) Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas. Clin Cancer Res 6:3748-3755.
28. Mayer LD, Bally MB, and Cullis PR (1986) Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta 857:123-126.
29. Mayer LD, Tai LC, Bally MB, Mitilenes GN, Ginsberg RS, and Cullis PR (1990) Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim Biophys Acta 1025:143-151.
30. Monsky WL, Kruskal JB, Lukyanov AN, Girnun GD, Ahmed M, Gazelle GS, Huertas JC, Stuart KE, Torchilin VP, and Goldberg SN (2002) Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model. Radiology 224:823-829.
31. Pelecanou M, Pirmettis IC, Papadopoulos MS, Raptopoulou CP, Terziz A, Chiotelis E, and Stassinopoulou CI (1999) Structural studies of ReO(V) mixed ligand [SNS][Cl] and [SNS][S] complexes. Inorg Chim Acta 287:142-151.
32. Phillips WT, Rudolph AS, Goins B, Timmons JH, Klipper R, and Blumhardt R (1992) A simple method for producing a technecium-99m-labeled liposome which is stable in vivo. Nucl Med Biol 19:539-547.
33. Pirmettis IC, Papadopoulos MS, Mastrostamatis CP, Raptopoulou CP, Terzis A, and Chiotellis E (1996) Synthesis and characterization of oxotechnetium(V) mixed-ligand complexes containing a tridentate N-substituted bis(2-mercaptoethyl) amine and a monodentate thiol. Inorg Chem 35:1685-1691.
34. Skubitz KM (2003) Phase II trial of pegylated-liposomal doxorubicin (Doxil) in sarcoma. Cancer Investig 21:167-176.
35. Syrigos KN, Michalaki B, Alevyzaki F, Machairas A, Mandrekas D, Kindilidis K, and Karatzas G (2002) A phase-II study of liposomal doxorubicin and docetaxel in patients with advanced pancreatic cancer. Anticancer Res 22:3583-3588.
36. Tilcock C (1999) Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound. Adv Drug Deliv Rev 37:33-51.
37. Tsavaris N, Kosmas C, Vadiaka M, Giannouli S, Siakantaris MP, Vassilakopoulos T, and Pangalis GA (2002) Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stage III/V) non-Hodgkin's lymphoma. Anticancer Res 22:1845-1848.
38. Unezaki S, Maruyama K, Takahashi N, Koyama M, Yuda T, Suginaka A, and Iwatsuru M (1994) Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia. Pharm Res (NY) 11:1180-1185.
39. 67Gallium-labeled liposomes with prolonged circulation: preparation and potential as nuclear imaging agents. Nucl Med Biol 20:149-155.